Proteolysis Targeting Chimera (PROTAC) as a Promising Novel Therapeutic Modality for the Treatment of Triple-Negative Breast Cancer (TNBC)

The authors give a brief overview of TNBC and PROTACs and highlight the rationale behind using PROTACs as a therapeutic modality in patients with TNBC.